1887

Abstract

SUMMARY

K-104 cells, a cloned cell line derived from a human neuroblastoma (SYM-I), were induced by rabies HEP-Flury virus to release large amounts of interferon, and the resulting antiviral activity significantly suppressed the rabies virus replication. The role of endogenous interferon was confirmed by treatment with anti-interferon antibody which increased the yield of progeny virus. The virus yield in the second undiluted passage through K-104 cells was much less than that in the first passage, because of the antiviral state initiated by brief contact of interferon present in the virus inoculum with cells during the short period of virus adsorption. When the m.o.i. was relatively low, as in the third undiluted passage, the effect of interferon present in the inoculum was enhanced and most of the infected cells survived but were shown to be in a state of persistent infection. Defective interfering (DI) particles did not accumulate rapidly during these three undiluted passages. When Sindbis virus was used for infection, the endogenous interferon system of K-104 cells was not activated during 12 undiluted passages. However, on the 12th passage, the yield began to decline due to the generation and accumulation of DI particles.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-65-10-1645
1984-10-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/65/10/JV0650101645.html?itemId=/content/journal/jgv/10.1099/0022-1317-65-10-1645&mimeType=html&fmt=ahah

References

  1. Baer G. M., Cleary W. F. 1972; A model in mice for the pathogenesis and treatment of rabies. Journal of Infectious Diseases 125:520–527
    [Google Scholar]
  2. Baer G. M., Yager P. A. 1977; A mouse model for post-exposure rabies prophylaxis: the comparative efficacy of two vaccines and of antiserum administration. Journal of General Virology 36:51–58
    [Google Scholar]
  3. Baer G. M., Shaddock J. H., Moore S. A., Yager P. A., Baron S. S., Levy H. B. 1977; Successful prophylaxis against rabies in mice and rhesus monkeys: the interferon system and vaccine. Journal of Infectious Diseases 136:286–291
    [Google Scholar]
  4. Baer G. M., Moore S. A., Shaddock J. H., Levy H. B. 1979; An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine. Bulletin of the World Health Organization 57:807–813
    [Google Scholar]
  5. Depoux R. 1965; Fixed rabies virus and interferon. Comptes rendus hebdomadaires des seances de I’Academie des Sciences, Serie D 260:354–356
    [Google Scholar]
  6. Fenje P., Postic B. 1971; Prophylaxis of experimental rabies with the polyriboinosinic-polyribocytidylic acid complex. Journal of Infectious Diseases 123:426–428
    [Google Scholar]
  7. Fukada T., Kawase Y., Ujihara M., Shin C., Shima T. 1968; Interference with virus infection induced by RNA in chick embryo cells. Japanese Journal of Microbiology 12:329–341
    [Google Scholar]
  8. Harmon M. W., Janis B. 1975; Therapy of murine rabies after exposure: efficacy of polyriboinosinic-poly-ribocytidylic acid alone and in combination with three rabies vaccines. Journal of Infectious Diseases 132:241–249
    [Google Scholar]
  9. Jacobson S., Mcfarland H. F. 1982; Measles virus persistence in human lymphocytes: a role for virus-induced interferon. Journal of General Virology 63:351–357
    [Google Scholar]
  10. Karakuyumchan M. K., Bektemirova M. S. 1968; Production and effect of interferon in experimental infection with fixed rabies virus. Voprosy virusologii 13:596–599
    [Google Scholar]
  11. Kawade Y. 1980; An an alysis of neutralization reaction of interferon by antibody: a proposal on the expression of neutralization titer. Journal of Interferon Research 1:61–70
    [Google Scholar]
  12. Kawai A. 1977; Transcriptase activity associated with rabies virion. Journal of Virology 24:826–835
    [Google Scholar]
  13. Kawai A., Matsumoto S. 1977; Interfering and noninterfering defective particles generated by a rabies small plaque variant virus. Virology 76:60–71
    [Google Scholar]
  14. Kawai A., Matsumoto S. 1982; A sensitive bioassay system for detecting defective interfering particles of rabies virus. Virology 122:98–108
    [Google Scholar]
  15. Kawai A., Matsumoto S., Tanabe K. 1975; Characterization of rabies viruses recovered from persistently infected BHK cells. Virology 67:520–533
    [Google Scholar]
  16. Linnavuori K., Hovi T. 1983; Restricted replication of herpes simplex virus in human monocyte cultures: role of interferon. Virology 130:1–9
    [Google Scholar]
  17. Madore H. P., England J. M. 1975; Selective suppression of cellular protein synthesis in BHK-21 cells infected with rabies virus. Journal of Virology 10:1351–1354
    [Google Scholar]
  18. Marcus P. I., Fuller F. J. 1979; Interferon induction by viruses. II. Sindbis virus: interferon induction requires one-quarter of the genome - genes G and A. Journal of General Virology 44:169–177
    [Google Scholar]
  19. Matsumoto S. 1974; Morphology of rabies virion and cytopathology of virus infected cells. Symposia Series in Immunobiological Standardization 21:25–34
    [Google Scholar]
  20. Mifune K., Shichijo A., Makino Y., Takeuchi E., Yamada A., Sakamoto K. 1980; A mouse model for the pathogenesis and postexposure prophylaxis of rabies. Microbiology and Immunology 24:835–845
    [Google Scholar]
  21. Murphy F. A. 1977; Rabies pathogenesis. Brief review. Archives of Virology 54:279–297
    [Google Scholar]
  22. Nagai Y., Ito Y., Hamaguchi M., Yoshida T., Matsumoto T. 1981; Relation of interferon production to the limited replication of Newcastle disease virus in L cells. Journal of General Virology 55:109–116
    [Google Scholar]
  23. Postic B., Fenje P. 1971; Effect of administered interferon on rabies in rabbits. Applied Microbiology 22:428–431
    [Google Scholar]
  24. Schlesinger S., Schlesinger M., Burge B. W. 1972; Defective virus particles from Sindbis virus. Virology 48:615–617
    [Google Scholar]
  25. Sedwick W. D., Wiktor T. J. 1967; Reproducible plaquing system for rabies, lymphocytic choriomeningitis, and other ribonucleic acid viruses in BHK-21/13S agarose suspensions. Journal of Virology 1:1224–1226
    [Google Scholar]
  26. Sekellick M. J., Marcus P. I. 1980; The interferon system as a regulator of persistent infection. Annals of the New York Academy of Sciences 350:545–557
    [Google Scholar]
  27. Stewart W. E. II 1981; Antiviral actions of interferons in animals. In The Interferon System 2nd edn., pp 266–291 Wien & New York: Springer-Verlag;
    [Google Scholar]
  28. Stewart W. E. II, Sulkin S. E. 1966; Interferon production in hamsters experimentally infected with rabies virus. Proceedings of the Society for Experimental Biology and Medicine 123:650–654
    [Google Scholar]
  29. Stewart W. E. II, Sulkin S. E. 1968; Evaluating the role of interferon in rabies infection. Bacteriological Proceedings 5:23
    [Google Scholar]
  30. Strauss J. H. Jr, Burge B. W., Darnell J. E. 1969; Sindbis virus infection of chick and hamster cells: synthesis of virus-specific proteins. Virology 37:367–376
    [Google Scholar]
  31. Vilcek J., Yamazaki S., Havelle E. A. 1977; Interferon induction by vesicular stomatitis virus and its role in virus replication. Infection and Immunity 18:863–865
    [Google Scholar]
  32. Wiktor T. J., Koprowski H., Rorke L. B. 1972a; Localized rabies infection in mice. Proceedings of the Society for Experimental Biology and Medicine 140:759–764
    [Google Scholar]
  33. Wiktor T. J., Postic B., Ho M., Koprowski H. 1972b; Role of interferon induction in protective activity of rabies vaccines. Journal of Infectious Diseases 126:408–418
    [Google Scholar]
  34. Wiktor T. J., Koprowski H., Mitchell J. R., Merigan T. C. 1976; Role of interferon in prophylaxis of rabies after exposure. Journal of Infectious Diseases 133:260–265
    [Google Scholar]
  35. Yoshino K., Taniguchi S., Arai K. 1966; Autointerference of rabies virus in chick embryo fibroblasts. Proceedings of the Society for Experimental Biology and Medicine 123:389–392
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-65-10-1645
Loading
/content/journal/jgv/10.1099/0022-1317-65-10-1645
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error